Aiyana Ishmael is the associate editor at Teen Vogue. In her work, Ishmael focuses primarily on the culture of fashion and how it specifically intertwines and affects marginalized communities.

During Friday’s media availability, Penn State basketball head coach Mike Rhoades announced that fifth-year senior Puff Johnson would be “out for a bit” with a right-hand injury. Penn State ...

Clear spells will become slightly more lengthy during this evening and overnight. Around dawn, the cloud will tend to replace most of these. It will be a dry and chilly night. Thursday Areas of ...

Penn State fifth-year senior Puff Johnson and freshman Hudson Ward are listed as out ahead of Monday’s game against Rutgers, per the Big Ten Availability Report. Puff Johnson (hand) and Hudson ...

Penn State (13-11, 3-10) could not keep up given its own shorthanded roster, swingman Puff Johnson (hand) and center Yanic Konan Niederhauser (ankle) both sidelined. Forward Zach Hicks (14 points ...

They’ll be without Puff Johnson due to a hand injury, according to a press release. He has not played for the Nittany Lions since January 15th. Johnson has averaged 10.2 points per game and 4.4 ...

Penn State basketball will be without guard/forward Puff Johnson for the foreseeable future after he suffered a right hand injury in Wednesday night's loss to Michigan State. Johnson exited the 90 ...

Fifth-year senior Puff Johnson will miss his fifth game this season against Ohio State (6:30 p.m. EST, FS1), per Penn State Athletics Strategic Communications. Johnson — who was averaging a ...

The Penn State basketball team suffered a big blow on the injury front at Michigan State last week when fifth-year senior Puff Johnson suffered an apparent right hand injury. And when the Nittany ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...